News
-
Envisioning the future: What should an HIV cure look like?
Modern HIV medications are powerful in both managing the infection and preventing its transmission and many of its…
-
Building Capacity for Community-Engaged Research: CTN+ Phase 2 Funding
As the Network moves into its second year of operations, with our Regional Teams and scientific Think Tanks…
-
Newborn screening for CMV catches overlooked infections
Somewhere between 1 in every 200 to 800 babies are born infected with cytomegalovirus (CMV). If undiagnosed, it…
-
Our commitment to unbiased and uncensored science
SILENCE = DEATH; This simple, direct and powerful statement launched a grass roots campaign that changed the history…
-
Unmasking the silent struggle: Living with chronic pain in the shadow of HIV
World AIDS Day December 1 is World AIDS Day, a global event that transcends borders and unites communities…
-
A call for community engagement: Exploring the harms and benefits of molecular HIV surveillance
“The first letter in HIV stands for Human,” writes Dr. Alexander McClelland in a co-authored 2020 paper outlining…
-
A Legacy of Integrity: Honouring Rosie’s 25 Years with the CTN
The first CTN study that Rosie worked on was the CTN164 STI study – that study belonged to…
-
Guest Blog: The two-year journey of a patient–researcher and CTN postdoctoral fellow
Dr. Serge Vicente recounts how his two-year journey as a CTN postdoctoral fellow helped him to consolidate his…
-
Hepatitis C cure does not remove all risks, CTN investigators find
CTN Investigators Drs. Naveed Janjua (Canadian lead) and Sofia Bartlett, along with a team of researchers from Canada…
